11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism
Authors:
- 20 July 2010
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 395 (7) , 963-967
Abstract
To evaluate whether dexamethasone suppression treatment can improve 11 C-metomidate positron emission tomography (MTO-PET) detection of small adrenocortical adenomas in primary aldosteronism (PA). Eleven patients with proven PA and two patients with non-hyperfunctioning adrenocortical incidentalomas and small adrenocortical tumours observed on CT underwent MTO-PET before and 3 days after administration of oral dexamethasone suppression treatment. Small “hot-spot” regions of interest comprising 4 pixels (SUVhs) and 1 pixel (SUVmax) were placed in the tumour area with the highest radioactivity concentration and their respective standardised uptake values (SUV) were recorded. All tumours were detected and categorised as adrenocortical by MTO-PET. SUVhs as well as SUVmax were higher in PA compared to nonfunctional adenomas. Normal adrenal cortex was suppressed after dexamethasone (p < 0.05), but tumour SUV was not significantly decreased after suppression in either PA or nonfunctional tumours (p > 0.05). However, these changes caused no significant increase in the tumour-to-normal adrenal ratio (p > 0.05). MTO-PET is a highly sensitive method for detecting and categorising even small adrenocortical tumours in PA. In this series, dexamethasone-suppressed MTO-PET was unable to increase the tumour-to-normal adrenal ratio to further facilitate detection of small adenomas in PA as an alternative to adrenal venous sampling.Keywords
This publication has 22 references indexed in Scilit:
- Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomasEuropean Journal of Radiology, 2009
- The role of radiologic studies in the evaluation and management of primary hyperaldosteronismSurgery, 2008
- Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenomaJournal Of Hypertension, 2008
- Cardiovascular Outcomes in Patients With Primary Aldosteronism After TreatmentArchives of internal medicine (1960), 2008
- Is Adrenal Venous Sampling Necessary in All Patients with Hyperaldosteronism before Adrenalectomy?Journal of Vascular and Interventional Radiology, 2008
- OUTCOMES OF LAPAROSCOPIC ADRENALECTOMY FOR HYPERLADOSTERONISMAnz Journal of Surgery, 2007
- Primary aldosteronism: diagnostic and treatment strategiesNature Clinical Practice Nephrology, 2006
- High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patientsJournal Of Hypertension, 2003
- Scintigraphic studies in adrenal hypertensionSeminars in Nuclear Medicine, 1989
- Scintigraphic localization of adrenal lesions in primary aldosteronismThe American Journal of Medicine, 1984